The page lists 36 projects related to the topic "immunomodulatory".
# | |||
---|---|---|---|
1 | DC cancer | Development and immunological control of dendritic cell cancer | 2015 |
2 | NANOTAM | Development and Evaluation of Nanomedicines for Cancer Treatment through Immunomodulation: Targeting Tumor-Associated Macrophages | 2015 |
3 | HBV1 | Innate immune responses to human hepatotropic viral infections | 2015 |
4 | IMMUTRAIN | Training Network for the Immunotherapy of Cancer | 2015 |
5 | SEPCELL | Title of Proposal: Restoring the immune system homeostasis and organ function in severe community acquired pneumonia- induced sepsis through adipose derived allogeneic stem cells (SEPCELL Proje | 2015 |
6 | CMIL | Crosstalk of Metabolism and Inflammation | 2016 |
7 | PIM PROTEOMICS | Unravelling PIM kinase signal integration in the T cell response | 2017 |
8 | PeptiCrad | Personalized oncolytic vaccines for cancer immunotherapy | 2016 |
9 | Fucoderm | An effective, side effect-free topical emollient treatment for atopic dermatitis made from a sustainably procured seaweed extract | 2016 |
10 | FiTTeR | Developing a Fibrosis Targeting and Tissue Reparative (FiTTeR) Therapy for the Infarcted Myocardium via an Injectable Functionalized Extracellular Matrix Hydrogel | 2017 |
11 | CureCN | Adeno-Associated Virus Vector-Mediated Liver Gene Therapy for Crigler-Najjar Syndrome | 2018 |
12 | CHIC | Chicory as a multipurpose crop for dietary fibre and medicinal terpenes | 2018 |
13 | NIRCOThera | Spatiotemporal, near-infrared light controlled carbon monoxide delivery for cancer immunotherapy | 2018 |
14 | BREFMC2017 | Deciphering the function(s) of the C-type lectin DCIR/CLEC4A in tuberculosis | 2018 |
15 | Tracer-T | Analysis of the effect of the tumour microenvironment on T cell functional phenotype | 2018 |
16 | SPArKLE | New players in immunometabolism: investigating the role of succinate and pyruvate kinase in T cell immunity | 2018 |
17 | MEXOM | Development and characterization of extracellular vesicles an innovative cell-free therapeutical product for treatment of stroke | 2018 |
18 | GLIAMAC | Uncovering Enteric GLIA-MACrophage communication in the intestinal homeostasis and inflammation | 2018 |
19 | UCRxF | A novel ulcerative colitis treatment - A phase III ready feasibility study | 2018 |
20 | EPIC | Enabling Precision Immuno-oncology in Colorectal cancer | 2018 |
21 | I-DireCT | Immune DIREcted and Cancer-selective immunoTherapy | 2019 |
22 | MechanoIMM | Mechanical Immunoengineering for Enhanced T-cell Immunotherapy | 2018 |
23 | NECESSITY | NEw Clinical Endpoints in primary Sjögren’s Syndrome: an Interventional Trial based on stratifYing patients | 2019 |
24 | GlyCANswer | Decoding the Cancer Glycoproteome Driven Immune Response | 2019 |
25 | MIMIC | Mapping and modulating integrin mediated interactions | 2020 |
26 | ScleroTest | A rapid and cost-effective point-of-care diagnostic kit able to predict treatment response for appropriate Multiple Sclerosis management | 2019 |
27 | Mirnagreen | First scalable food-grade technology for the direct extraction and purification of miRNAs-rich extracts from plants | 2019 |
28 | TEXAD | TEXAD – Tailoring EXosomes for Autoimmune Diseases | 2019 |
29 | ANIMATE | Adaptive Immunity in Human Atherosclerosis: Understanding its Cellular Basis to Define Novel Immunomodulatory Therapies | 2020 |
30 | FAIR | FLAGELLIN AEROSOL THERAPY AS AN IMMUNOMODULATORY ADJUNCT TO THE ANTIBIOTIC TREATMENT OF DRUG-RESISTANT BACTERIAL PNEUMONIA | 2020 |
31 | ExocyTher | Extracellular vesicle production and engineering by turbulence for fistula therapy in thermoreversible hydrogels | 2020 |
32 | VANGUARD | New Generation Cell Therapy: Bioartificial Pancreas to Cure Type 1 Diabetes | 2020 |
33 | Meta-Targeting | Macro-Nanomedicine to Treat Metastatic Cancer | 2020 |
34 | Glue2Degrade | Therapeutic hijacking of E3 Ligases | 2020 |
35 | BraINstorm | Engineered nanocarriers for simultaneous anticancer immune response and “switching” of tumor-associated macrophages for intranasal glioblastoma treatment | 2020 |
36 | MiNeMI | Micronnedle-assisted nanovector skin patch for immunomodulation of the inflammatory response upon occurrence of myocardial infarction injury (MiNeMi) | 2020 |